Replies to post #155680 on Biotech Values

[mcbio]

Telik (TELK) says it's completed its End of Phase 2 meeting with the FDA for its MDS treatment Telintra, with a preliminary agreement reached regarding the design of a Phase 3 trials.

Hopefully Telintra arm doesn't cause quicker death than the control arm. What a miserable history TELK has had.

[dav1234]

pound for pound of market cap, TELK is worth a shot imo,probably best to wait a bit for the inevitable raise thou.